Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Specific Population

People who inject or use drugs (1)

Filter by Topic

Treatment (remove)
- Hepatitis C drugs (remove)
  - Zepatier (remove)
  - Maviret (1)
  - Vosevi (1)
Infections and cancers (1)
Organ and body health (1)

Filter by Infection

Hepatitis C (remove)
HIV (1)

Filter by Resource Category

Search results

Current filters: Treatment, Hepatitis C drugs, Hepatitis C, Zepatier

6 search results

FDA—Rare cases of liver injury with some hepatitis C treatments: 2019, CATIE
Research summary - Webpage
Zepatier (elbasvir + grazoprevir): 2019, CATIE
Fact sheet - Webpage
Zepatier in people grappling with drug addiction: From TreatmentUpdate 213
2016, CATIE
Research summary - Webpage
Zepatier in HCV and HIV co-infection: From TreatmentUpdate 213
2016, CATIE
Research summary - Webpage
Zepatier in cirrhosis: From TreatmentUpdate 213
2016, CATIE
Research summary - Webpage
Zepatier in hepatitis C virus genotype 1a: From TreatmentUpdate 213
2016, CATIE
Research summary - Webpage

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.